MilliporeSigma
  • Home
  • Search Results
  • Expression and regulation of toll-like receptors (TLRs) in human intervertebral disc cells.

Expression and regulation of toll-like receptors (TLRs) in human intervertebral disc cells.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2014-07-06)
Marina Klawitter, Michiyuki Hakozaki, Hiroshi Kobayashi, Olga Krupkova, Lilian Quero, Caroline Ospelt, Steffen Gay, Oliver Hausmann, Thomas Liebscher, Ullrich Meier, Miho Sekiguchi, Shin-ichi Konno, Norbert Boos, Stephen J Ferguson, Karin Wuertz
ABSTRACT

Although inflammatory processes play an essential role in painful intervertebral disc (IVD) degeneration, the underlying regulatory mechanisms are not well understood. This study was designed to investigate the expression, regulation and importance of specific toll-like receptors (TLRs)--which have been shown to play an essential role e.g. in osteoarthritis--during degenerative disc disease. The expression of TLRs in human IVDs was measured in isolated cells as well as in normal or degenerated IVD tissue. The role of IL-1β or TNF-α in regulating TLRs (expression/activation) as well as in regulating activity of down-stream pathways (NF-κB) and expression of inflammation-related genes (IL-6, IL-8, HSP60, HSP70, HMGB1) was analyzed. Expression of TLR1/2/3/4/5/6/9/10 was detected in isolated human IVD cells, with TLR1/2/4/6 being dependent on the degree of IVD degeneration. Stimulation with IL-1β or TNF-α moderately increased TLR1/TLR4 mRNA expression (TNF-α only), and strongly increased TLR2 mRNA expression (IL-1β/TNF-α), with the latter being confirmed on the protein level. Stimulation with IL-1β, TNF-α or Pam3CSK4 (a TLR2-ligand) stimulated IL-6 and IL-8, which was inhibited by a TLR2 neutralizing antibody for Pam3CSK4; IL-1β and TNF-α caused NF-κB activation. HSP60, HSP70 and HMGB1 did not increase IL-6 or IL-8 and were not regulated by IL-1β/TNF-α. We provide evidence that several TLRs are expressed in human IVD cells, with TLR2 possibly playing the most crucial role. As TLRs mediate catabolic and inflammatory processes, increased levels of TLRs may lead to aggravated disc degeneration, chronic inflammation and pain development. Especially with the identification of more endogenous TLR ligands, targeting these receptors may hold therapeutic promise.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
Nitrogen, ≥99.998%
Sigma-Aldrich
Nitrogen, ≥99.999%
Sigma-Aldrich
Anti-RELA (Ab-468) antibody produced in rabbit, affinity isolated antibody
Ampicillin, anhydrous, European Pharmacopoeia (EP) Reference Standard
USP
Ampicillin, United States Pharmacopeia (USP) Reference Standard
Supelco
Ampicillin, analytical standard
Sigma-Aldrich
Ampicillin, meets USP testing specifications
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2A3, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2D2, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 3F10, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 1E3, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 4D6, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 4G9, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 1C6, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 1B10, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 4C4, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-RELA (Ab-254) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-RELA (Ab-276) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-RELA (Ab-435) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-RELA (Ab-311) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-RELA (Ab-529) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-RELA (Ab-536) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-RELA (Ab-505) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 3H8, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-TLR2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-TLR2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-TLR2 antibody produced in mouse, clone 4H6, purified immunoglobulin, buffered aqueous solution